Post Surgery Patient Articles & Analysis
6 news found
The aim of the announced Phase 3 clinical programme is to deliver comprehensive clinical trial data demonstrating that nasal decolonisation using XF-73 Nasal, alongside “standard of care”, reduces the incidence of post-surgical infections in patients. This meets the requirements of both the US and EU regulators – the FDA and EMA. After a ...
The VOIS stands out in the eyes of reviewers with special features including standardized procedure with high result-reproducibility and implant adjustability (intra- and post-operative), making revision surgeries redundant, providing patients with long-term benefits and values rise above. ...
"A lack of strong rebound in CRS symptoms post-treatment and removal is very exciting, with potential long-term benefit for CRS patients. ...
Head and neck cancer surgery presents a number of unique challenges, not only for the surgeon but for the radiation oncologist who will subsequently treat those patients. ...
Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the receipt of an Investigational Device Exemption (IDE) from the FDA – enabling the company to conduct the first long-term clinical trial of its ultra-miniaturized neuromodulation platform. An MRI Conditional version of Neuspera’s wirelessly powered implant designed for use as ...
The new Director of Breast Surgery and Women’s Health for the breast surgery center at the Albert Einstein Healthcare Network has a very simple reason for dedicating his life to his profession. ...